Advantage Alpha Capital Partners LP Invests $2.25 Million in Privia Health Group, Inc. (NASDAQ:PRVA)

Advantage Alpha Capital Partners LP purchased a new position in Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 115,227 shares of the company's stock, valued at approximately $2,253,000. Advantage Alpha Capital Partners LP owned about 0.10% of Privia Health Group as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in PRVA. First Horizon Advisors Inc. lifted its stake in shares of Privia Health Group by 53.8% in the 4th quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company's stock valued at $35,000 after acquiring an additional 632 shares during the last quarter. EverSource Wealth Advisors LLC increased its stake in Privia Health Group by 7,833.3% in the 4th quarter. EverSource Wealth Advisors LLC now owns 2,380 shares of the company's stock worth $47,000 after purchasing an additional 2,350 shares during the period. Financial Management Professionals Inc. bought a new position in shares of Privia Health Group in the fourth quarter worth approximately $51,000. Quarry LP increased its stake in shares of Privia Health Group by 344.6% in the third quarter. Quarry LP now owns 3,268 shares of the company's stock worth $60,000 after buying an additional 2,533 shares during the period. Finally, KBC Group NV grew its holdings in Privia Health Group by 34.6% in the 3rd quarter. KBC Group NV now owns 3,385 shares of the company's stock worth $62,000 after acquiring an additional 871 shares during the last quarter. 94.48% of the stock is currently owned by hedge funds and other institutional investors.

Remove Ads

Privia Health Group Stock Performance

Shares of PRVA traded down $0.22 on Friday, hitting $22.70. 40,217 shares of the stock traded hands, compared to its average volume of 751,991. Privia Health Group, Inc. has a one year low of $15.92 and a one year high of $26.04. The business has a 50 day simple moving average of $23.79 and a 200 day simple moving average of $21.13. The company has a market capitalization of $2.74 billion, a PE ratio of 227.21, a P/E/G ratio of 3.47 and a beta of 0.85.

Wall Street Analyst Weigh In

Several analysts recently issued reports on the company. Needham & Company LLC reissued a "buy" rating and issued a $30.00 target price on shares of Privia Health Group in a research note on Friday, March 21st. Macquarie assumed coverage on Privia Health Group in a research note on Monday, December 16th. They issued an "outperform" rating and a $25.00 price target for the company. Piper Sandler boosted their price objective on shares of Privia Health Group from $25.00 to $40.00 and gave the company an "overweight" rating in a research report on Friday, February 28th. Canaccord Genuity Group lifted their target price on shares of Privia Health Group from $29.00 to $30.00 and gave the company a "buy" rating in a research note on Friday, February 28th. Finally, Stephens reissued an "overweight" rating and issued a $26.00 price target on shares of Privia Health Group in a research note on Thursday, January 2nd. One investment analyst has rated the stock with a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, Privia Health Group has an average rating of "Buy" and an average target price of $26.67.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.